Laurel Bridge Software announces that IMIDEX, Inc., an Artificial Intelligence (AI) solution provider focused on lung cancer, has selected its Compass™ Routing Workflow Manager and Exodus™ Migration and Consolidation Controller to facilitate a retrospective, multi-center clinical study for the detection of incidental lung nodules using their computer-aided detection application VisiRad™.
The detection of lung nodules on chest radiographs is challenging, with detection sensitivities in clinical practice ranging between 30-70%. VisiRad aims to provide a second set of eyes to increase the sensitivity of lung nodule detection to help identify lung cancers at an earlier stage. The Laurel Bridge Software imaging workflow solution that incorporates Compass and Exodus into the VisiRad workflow facilitates anonymization, routing, and migration of images, supporting the clinical study as VisiRad undergoes research for a pending FDA clearance.
Read more about this exciting, new collaboration in the press release and in the recent PR Newswire story.